寄生虫与 COVID-19 易感性、疾病进展和疫苗效力。
Helminths and COVID-19 susceptibility, disease progression, and vaccination efficacy.
机构信息
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.
出版信息
Trends Parasitol. 2022 Apr;38(4):277-279. doi: 10.1016/j.pt.2022.01.007. Epub 2022 Jan 19.
Abstract
Almost 2 years into the coronavirus disease 2019 (COVID-19) pandemic, it remains to be determined how helminths interact with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We discuss how helminths may alter susceptibility to infection, COVID-19 pathology, and the efficiency of vaccines by combined analysis of available COVID-19 data and previous investigations of the effect of helminths in viral infections.
摘要
在新冠肺炎（COVID-19）大流行近 2 年后，仍然需要确定寄生虫如何与严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）相互作用。我们通过对现有 COVID-19 数据和寄生虫对病毒感染影响的先前研究的综合分析，讨论了寄生虫如何改变对感染的易感性、COVID-19 病理和疫苗的效率。
相似文献
1
Helminths and COVID-19 susceptibility, disease progression, and vaccination efficacy.寄生虫与 COVID-19 易感性、疾病进展和疫苗效力。
Trends Parasitol. 2022 Apr;38(4):277-279. doi: 10.1016/j.pt.2022.01.007. Epub 2022 Jan 19.
2
Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.基于 SARS-CoV-2 的免疫原性结构蛋白、宿主免疫反应和群体免疫的 COVID-19 疫苗开发的新见解。
Cells. 2021 Oct 29;10(11):2949. doi: 10.3390/cells10112949.
3
Challenges and prospects of COVID-19 vaccine development based on the progress made in SARS and MERS vaccine development.基于 SARS 和 MERS 疫苗研发进展的 COVID-19 疫苗研发的挑战与前景。
Transbound Emerg Dis. 2021 May;68(3):1111-1124. doi: 10.1111/tbed.13804. Epub 2020 Sep 23.
4
Serologic Status According Severe Acute Respiratory Syndrome Coronavirus 2 in Patients After Orthotopic Heart Transplantation.心脏移植术后患者的严重急性呼吸综合征冠状病毒 2 血清学状态。
Transplant Proc. 2022 May;54(4):901-904. doi: 10.1016/j.transproceed.2022.02.044. Epub 2022 Mar 16.
5
Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.确定 COVID-19 疫苗早期接种者中无症状 SARS-CoV-2 的发病率（DISCOVER-COVID-19）：疫苗接种前、接种中和接种后的医护人员前瞻性队列研究。
Clin Infect Dis. 2022 Apr 9;74(7):1275-1278. doi: 10.1093/cid/ciab643.
6
Cross-protective immunity following coronavirus vaccination and coronavirus infection.冠状病毒疫苗接种和感染后的交叉保护免疫。
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI151969.
7
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19（Sars-Cov-2）的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
8
Trilogy of COVID-19: Infection, Vaccination, and Immunosuppression.COVID-19 的三部曲：感染、疫苗接种和免疫抑制。
Int Arch Allergy Immunol. 2022;183(8):888-906. doi: 10.1159/000524056. Epub 2022 Apr 7.
9
Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8 T cell responses.非中和抗体依赖的 SARS-CoV-2 控制与鼻内疫苗诱导的 CD8 T 细胞反应相关。
Cell Rep Med. 2022 Jan 19;3(2):100520. doi: 10.1016/j.xcrm.2022.100520. eCollection 2022 Feb 15.
10
SARS-CoV-2 Seroconversion in Response to Infection and Vaccination: a Time Series Local Study in Brazil.巴西一项时间序列的本地研究：感染和接种疫苗后针对 SARS-CoV-2 的血清转化。
Microbiol Spectr. 2022 Aug 31;10(4):e0102622. doi: 10.1128/spectrum.01026-22. Epub 2022 Jun 30.
引用本文的文献
1
Characteristics of SARS-CoV-2 and Opisthorchis viverrini coinfections: insights into immune responses and clinical outcomes.华支睾吸虫与 SARS-CoV-2 合并感染的特征：对免疫反应和临床结局的洞察。
Parasitol Res. 2024 Aug 9;123(8):297. doi: 10.1007/s00436-024-08317-8.
2
Soil-transmitted helminths: A critical review of the impact of co-infections and implications for control and elimination.土壤传播性蠕虫：合并感染的影响及其对控制和消除的意义的批判性综述。
PLoS Negl Trop Dis. 2023 Aug 10;17(8):e0011496. doi: 10.1371/journal.pntd.0011496. eCollection 2023 Aug.
3
Antigens from the Helminth Exert Antiviral Effects against SARS-CoV-2 In Vitro.寄生虫抗原在体外对 SARS-CoV-2 具有抗病毒作用。
Int J Mol Sci. 2023 Jul 18;24(14):11597. doi: 10.3390/ijms241411597.
4
COVID-19 morbidity in lower versus higher income populations underscores the need to restore lost biodiversity of eukaryotic symbionts.低收入人群与高收入人群中新冠病毒感染率的差异凸显了恢复真核共生生物已丧失生物多样性的必要性。
iScience. 2023 Mar 17;26(3):106167. doi: 10.1016/j.isci.2023.106167. Epub 2023 Feb 9.
5
Helminth exposure protects against murine SARS-CoV-2 infection through macrophage dependent T cell activation.蠕虫感染通过巨噬细胞依赖性T细胞激活来预防小鼠感染SARS-CoV-2。
bioRxiv. 2022 Nov 10:2022.11.09.515832. doi: 10.1101/2022.11.09.515832.
6
A New Role for Old Friends: Effects of Helminth Infections on Vaccine Efficacy.老朋友的新角色：蠕虫感染对疫苗效力的影响
Pathogens. 2022 Oct 8;11(10):1163. doi: 10.3390/pathogens11101163.
本文引用的文献
1
Update on SARS-CoV-2 seroprevalence: regional and worldwide.关于 SARS-CoV-2 血清流行率的最新信息：地区和全球。
Clin Microbiol Infect. 2021 Dec;27(12):1762-1771. doi: 10.1016/j.cmi.2021.09.019. Epub 2021 Sep 25.
2
Helminth-virus interactions: determinants of coinfection outcomes.寄生虫-病毒相互作用：共感染结局的决定因素。
Gut Microbes. 2021 Jan-Dec;13(1):1961202. doi: 10.1080/19490976.2021.1961202.
3
Effect of co-infection with intestinal parasites on COVID-19 severity: A prospective observational cohort study.肠道寄生虫共感染对新冠病毒疾病严重程度的影响：一项前瞻性观察队列研究。
EClinicalMedicine. 2021 Sep;39:101054. doi: 10.1016/j.eclinm.2021.101054. Epub 2021 Jul 31.
4
Chronic Immune Activation and CD4 T Cell Lymphopenia in Healthy African Individuals: Perspectives for SARS-CoV-2 Vaccine Efficacy.慢性免疫激活与 CD4+T 细胞耗竭在健康非洲人群中的状况：对 SARS-CoV-2 疫苗有效性的启示。
Front Immunol. 2021 Jun 17;12:693269. doi: 10.3389/fimmu.2021.693269. eCollection 2021.
5
Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19.严重 COVID-19 患者肺部炎症由髓系细胞驱动的呼吸道和全身免疫反应纵向分析。
Immunity. 2021 Apr 13;54(4):797-814.e6. doi: 10.1016/j.immuni.2021.03.005. Epub 2021 Mar 11.
6
Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.特发性肺纤维化和 COVID-19 严重程度之间存在共享的遗传病因。
EBioMedicine. 2021 Mar;65:103277. doi: 10.1016/j.ebiom.2021.103277. Epub 2021 Mar 10.
7
Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey.2020 年 7 月赞比亚六个地区 SARS-CoV-2 的流行情况：一项横断面聚类样本调查。
Lancet Glob Health. 2021 Jun;9(6):e773-e781. doi: 10.1016/S2214-109X(21)00053-X. Epub 2021 Mar 9.
8
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic.英格兰在大流行首次高峰后 SARS-CoV-2 抗体流行率。
Nat Commun. 2021 Feb 10;12(1):905. doi: 10.1038/s41467-021-21237-w.
9
SARS-CoV-2 in the Amazon region: A harbinger of doom for Amerindians.新冠病毒在亚马逊地区：美洲原住民的厄运先兆。
PLoS Negl Trop Dis. 2020 Oct 29;14(10):e0008686. doi: 10.1371/journal.pntd.0008686. eCollection 2020 Oct.
10
Longitudinal analyses reveal immunological misfiring in severe COVID-19.纵向分析揭示了重症 COVID-19 中的免疫失调。
Nature. 2020 Aug;584(7821):463-469. doi: 10.1038/s41586-020-2588-y. Epub 2020 Jul 27.
Zotero 插件